{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Scottsdale",
      "address_1": "7373 N. Scottsdale Rd., Suite B-200",
      "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.",
      "address_2": "",
      "product_quantity": "135,277 bottles",
      "code_info": "All lots within expiry.",
      "center_classification_date": "20180209",
      "distribution_pattern": "Nationwide in the USA.",
      "state": "AZ",
      "product_description": "Limbrel (flavocoxid 500 mg) capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsdale, AZ  85253; Manufactured by: Cornerstone Research and Development, Ogden, UT  84404, NDC 68040-602-16.",
      "report_date": "20180221",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Primus Pharmaceuticals, Inc.",
      "recall_number": "D-0345-2018",
      "initial_firm_notification": "Press Release",
      "product_type": "Drugs",
      "event_id": "79055",
      "termination_date": "20190716",
      "more_code_info": "",
      "recall_initiation_date": "20180126",
      "postal_code": "85253",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}